JP2022533855A5 - - Google Patents
Info
- Publication number
- JP2022533855A5 JP2022533855A5 JP2021569941A JP2021569941A JP2022533855A5 JP 2022533855 A5 JP2022533855 A5 JP 2022533855A5 JP 2021569941 A JP2021569941 A JP 2021569941A JP 2021569941 A JP2021569941 A JP 2021569941A JP 2022533855 A5 JP2022533855 A5 JP 2022533855A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- nos
- antibody
- amino acid
- chain variable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910464016 | 2019-05-30 | ||
| CN201910464016.0 | 2019-05-30 | ||
| PCT/CN2020/092766 WO2020238998A1 (en) | 2019-05-30 | 2020-05-28 | Anti-trka antibodies and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022533855A JP2022533855A (ja) | 2022-07-26 |
| JP2022533855A5 true JP2022533855A5 (cg-RX-API-DMAC7.html) | 2022-08-02 |
| JP7671699B2 JP7671699B2 (ja) | 2025-05-02 |
Family
ID=73506735
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021569941A Active JP7671699B2 (ja) | 2019-05-30 | 2020-05-28 | 抗TrkA抗体及びその使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20220204630A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3976657A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7671699B2 (cg-RX-API-DMAC7.html) |
| CN (2) | CN112010978B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2020281378B2 (cg-RX-API-DMAC7.html) |
| TW (1) | TWI908724B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020238998A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2021382828A1 (en) * | 2020-11-20 | 2022-10-06 | Sunshine Lake Pharma Co., Ltd. | Humanized anti-TrkA antibodies and uses thereof |
| CN112961244B (zh) * | 2021-02-28 | 2023-08-29 | 熙源安健医药(上海)有限公司 | 抗TrkA抗体或其抗原结合片段、其制备方法和应用 |
| WO2023125490A1 (en) * | 2021-12-28 | 2023-07-06 | 4B Technologies (Suzhou) Limited | TrkA ANTIBODY AND APPLICATION THEREOF |
| CN115611985B (zh) * | 2022-10-27 | 2026-07-10 | 合肥天港免疫药物有限公司 | 抗cd3的抗体及其应用 |
| WO2024191900A2 (en) * | 2023-03-10 | 2024-09-19 | The J. David Gladstone Institutes, A Testamentary Trust Established Under The Will Of J. David Gladstone | Methods and compositions for cellular immunotherapy – fib4 |
| WO2025079006A1 (en) | 2023-10-13 | 2025-04-17 | Cephalon Llc | Anti-trka antibodies and uses thereof |
| CN120058930B (zh) * | 2025-02-27 | 2026-05-29 | 中国医学科学院基础医学研究所 | 一种靶向神经营养因子BDNF和NGF的IgA抗体及其应用 |
| CN120360963B (zh) * | 2025-04-23 | 2026-02-27 | 广州芬瑞生物科技有限公司 | 干细胞外泌体制备方法及该方法制备的外泌体在治疗男性勃起功能障碍中的用途 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6833268B1 (en) | 1999-06-10 | 2004-12-21 | Abgenix, Inc. | Transgenic animals for producing specific isotypes of human antibodies via non-cognate switch regions |
| GB0326780D0 (en) * | 2003-11-18 | 2003-12-24 | Imp College Innovations Ltd | Biological materials and uses thereof |
| JP4958555B2 (ja) * | 2004-09-22 | 2012-06-20 | 協和発酵キリン株式会社 | 安定化されたヒトIgG4抗体 |
| ITRM20050290A1 (it) * | 2005-06-07 | 2006-12-08 | Lay Line Genomics Spa | Uso di molecole in grado di inibire il legame tra ngf e il suo recettore trka come analgesici ad effetto prolungato. |
| BRPI0905955A8 (pt) * | 2008-02-04 | 2018-05-08 | Lay Line Genomics Spa | anticorpo ani trka, anticorpo ou derivado, derivado de um anticorpo, combinação de um anticorpo ou derivado, composição farmaceutica, método, polipetídeo, ácido nucléico codificante de um aniticorpo ou derivado do mesmo, vetor, sistema de expressão ,mamífero transgênico não humano e kit compreendo um anticorpo ou derivado |
| US8183346B2 (en) * | 2008-12-05 | 2012-05-22 | Eli Lilly And Company | Anti-ferroportin 1 monoclonal antibodies and uses thereof |
| DK2766392T3 (da) * | 2011-10-10 | 2019-10-07 | Xencor Inc | Fremgangsmåde til oprensning af antistoffer |
| UA113879C2 (xx) * | 2012-06-08 | 2017-03-27 | ГУМАНІЗОВАНЕ АНТИТІЛО ПРОТИ ТrkА З АМІНОКИСЛОТНИМИ ЗАМІЩЕННЯМИ | |
| EP2674439B1 (en) * | 2012-06-13 | 2017-02-01 | Rottapharm Biotech S.r.l. | Anti-TrkA antibodies, derivatives and uses thereof |
| MA41097A (fr) * | 2014-12-05 | 2017-10-10 | Glenmark Pharmaceuticals Sa | Anticorps anti-trka à propriétés inhibitrices améliorées et dérivés desdits anticorps destinés à être utilisés pour traiter les douleurs osseuses |
| WO2018042018A2 (en) * | 2016-09-02 | 2018-03-08 | European Molecular Biology Laboratory | Irradiation treatment of neurological sensations by photoablation |
| WO2018166461A1 (en) | 2017-03-14 | 2018-09-20 | Sunshine Lake Pharma Co., Ltd. | Dual-target fusion proteins comprising the fc portion of an immunoglobulin |
-
2020
- 2020-05-28 AU AU2020281378A patent/AU2020281378B2/en active Active
- 2020-05-28 US US17/604,728 patent/US20220204630A1/en active Pending
- 2020-05-28 EP EP20814249.7A patent/EP3976657A4/en active Pending
- 2020-05-28 WO PCT/CN2020/092766 patent/WO2020238998A1/en not_active Ceased
- 2020-05-28 JP JP2021569941A patent/JP7671699B2/ja active Active
- 2020-05-28 CN CN202010465851.9A patent/CN112010978B/zh active Active
- 2020-05-28 CN CN202111390356.7A patent/CN114230663B/zh active Active
- 2020-05-29 TW TW109118203A patent/TWI908724B/zh active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2022221560A1 (en) | TREM2 antigen binding proteins and uses thereof | |
| EP2997042B1 (en) | Anti-cxcl1, cxcl7 and cxcl8 antibodies and their applications | |
| EP3689370B1 (en) | Anti-gdf15 antibodies | |
| JP6779252B2 (ja) | IL−1βへの結合メンバー | |
| DK3004167T3 (en) | ONCOSTATIN M-RECEPTOR ANTIGIN BINDING PROTEINS | |
| EP4480967A1 (en) | Development and use of novel immunomodulator | |
| EP3233897B1 (en) | Anti il-34 antibodies | |
| RU2018129874A (ru) | Антитела против фактора свертывания xi | |
| CN105358175B (zh) | 用于治疗硬皮病的抗ccl2和抗loxl2组合疗法 | |
| JP2009529920A5 (cg-RX-API-DMAC7.html) | ||
| AU2020390028B2 (en) | Pharmaceutical composition, preparation method therefor and use thereof | |
| JP2017517507A (ja) | 急性骨髄性白血病を特徴付け、治療する方法 | |
| JP2022533855A (ja) | 抗TrkA抗体及びその使用 | |
| US20240409625A9 (en) | Engineered dual binding antibodies and uses thereof | |
| US11623951B2 (en) | Antibodies to R-spondin 3 | |
| CN114516917B (zh) | 人源化抗TrkA的抗体及其应用 | |
| JP2023549300A5 (cg-RX-API-DMAC7.html) | ||
| JP7643727B2 (ja) | 抗-fgf19抗体 | |
| CA2971517C (en) | Anti il-34 antibodies | |
| CN121532429A (zh) | Mhc i类链相关蛋白a (mica)特异性抗体及其用途 |